A groundbreaking injectable drug, lenacapavir, offers renewed hope in the fight against HIV. Set to be available in 2027 in ...
A partnership will enable low-cost, generic lenacapavir for HIV prevention in LMICs, aiming to improve access and reduce ...
An HIV prevention drug will be made available at a new, low cost in 120 low- and middle-income countries starting in 2027, according to an announcement yesterday. The move is being called a “once-in-a ...
Gilead's groundbreaking HIV prevention drug will soon be available at a fraction of its U.S. price in over 100 countries, ...
Cheap generic versions of a groundbreaking HIV-prevention jab should be available in more than 100 countries from 2027, ...
Lenacapavir, approved by the FDA in June, requires only two shots a year. US insurers don't cover it, but access will soon ...
ZIMBABWE has been selected as one of only ten countries globally to roll out lenacapavir, a groundbreaking HIV prevention drug that could transform the fight against the epidemic.The announcement was ...
New infections drop 44 percent | The Herald (Top Stories) Raymond Jaravaza, [email protected] THE number of people living with HIV in Bulawayo has declined from 79 711 in 2020 to 76 608 in 2024, ...
This is American leadership at its best: driving innovation, and building a world where children, mothers, and communities ...
The CDC made a strong recommendation based on a high certainty of evidence to use the long-acting injectable lenacapavir ...